Mariana Baz Etchebarne
Chercheuse universitaire
Axe Maladies infectieuses et immunitaires
Virologie
Virologie médicale
Résistance aux antiviraux
Vaccins
Pathogenèse
Microbiologie médicale
Publications
View all-
article Bolduc M, Saint-Louis P, Carignan D, Garneau C, Breton Y, Pelletier M, Rancourt A, Satoh MS, Sato S, Gilbert M, Rabezanahary H, Baz M, Dubuc I, Flamand L, Leclerc D
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines
Nanomedicine 71 2026.
-
article Wantchecon A, Boucher J, Rabezanahary H, Gilbert C, Baz M
Comparative Analysis of Extracellular Vesicle and Virus Co-Purified Fractions Produced by Contemporary Influenza A and B Viruses in Different Human Cell Lines
Viruses 17 (11), 2025.
-
article Thériault M, Santerre K, Brousseau N, Rochette S, Omar RF, Pelletier JN, Gilbert C, Masson JF, Baz M, Boudreau D, Trottier S
Profile, Infection, and Vaccination Uptake: A Cohort of Canadian Retail Workers During the SARS-CoV-2 Pandemic
Infect Dis Rep 17 (5), 2025.
Projects
- Canada Research Chair in Pre-pandemic and Pandemic viruses and therapeutic strategies, from 2023-05-01 to 2028-04-29
- Développement de tests sérologiques pour les virus respiratoires et les virus de la variole du singe., from 2023-04-01 to 2028-03-31
- The Pursuit of a SARS-CoV-2 Vaccine: Aiming for Broad Protection, from 2024-12-01 to 2026-11-30
- National Primate Center for Pandemic Preparedness (NPCPP), from 2024-03-01 to 2028-03-31
- FGR-Optimisation et caractérisation d'un modèle de furet immunosupprimé pour l'étude de la réplication et la transmission du virus d'influenza, from 2025-03-24 to 2026-03-23
- Virus pré-pandémiques et pandémiques et stratégies thérapeutiques, from 2023-04-01 to 2025-12-31
- Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer, from 2023-03-01 to 2024-02-29
- Plateforme de laboratoire de niveau de confinement 3 pour la recherche sur les virus émergents, from 2023-01-31 to 2025-03-31
- Optimization of a live microneutralization assay to evaluate antibody levels against mpox in vaccinated or infected individuals in Quebec, from 2023-04-24 to 2024-04-23
- Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?, from 2024-09-01 to 2025-08-31
- Establishing a One Health sentinel cohort for Highly Pathogenic Avian Influenza, from 2024-09-01 to 2025-08-31